Hepatitis B News and Research

Latest Hepatitis B News and Research

Hep C and HIV among injecting drug users in London are higher than expected

Levels of hepatitis C virus and HIV among injecting drug users in London are higher than expected, according to a study published online by the BMJ.

14 Nov 2004

Caspase levels associated with liver injury

Caspase activity in the sera of patients with chronic hepatitis C infection (HCV) may be a more sensitive measure of liver injury than conventional surrogate markers like aminotransferases, according to a new study published in the November 2004 issue of Hepatology.

8 Nov 2004

Prevalence of occult HBV in hemodialysis patients is 4 to 5 times higher than standard HBsAg testing would suggest

Some kidney dialysis patients contract hepatitis B virus (HBV) during the course of their treatment, possibly from other members of the dialysis population with occult HBV.

8 Nov 2004

Britain should adopt universal hepatitis B immunisation

The United Kingdom is one of the few developed countries that have not implemented universal immunisation. Because the burden of hepatitis B was low and individual rights were considered paramount, a policy of selective immunisation of high-risk groups, such as health care workers, homosexual men, and drug addicts, has been followed.

5 Nov 2004

Researchers identify biomarkers that could lead to more accurate diagnosis of systemic lupus erythematosus

University of Pittsburgh researchers have identified biomarkers that could result in earlier and more accurate diagnosis of systemic lupus erythematosus (SLE), a devastating disease that affects as many as 1.5 million Americans, and occurs 10 to 15 times more frequently in women.

4 Nov 2004

Health professionals fall short for Hepatitis C patients

People living with Hepatitis C are highly critical of the treatment they have received from health professionals, particularly doctors, according to a new study by a University of Auckland sociology researcher.

3 Nov 2004

Analysis of safety syringe market

One of the biggest challenges facing manufacturers of safety syringes in Europe is the lack of legislation on the use of these products in health care settings.

2 Nov 2004

Program triples hepatitis B vaccination rates in targeted regions of rural China

The Bristol-Myers Squibb Foundation and the China Foundation for Hepatitis Prevention and Control (CFHPC) announced the results of a collaborative grassroots education and vaccination program designed to fight the spread of one of China's most pressing health problems -- hepatitis B.

1 Nov 2004

New approaches for the treatment of chronic hepatitis C

Data from two ongoing studies testing new approaches for the treatment of chronic hepatitis C was presented at the annual meeting of the American Association for the Study of Liver Diseases (AASLD) this afternoon.

1 Nov 2004

Discovery of a number of potent and selective small molecule inhibitors of the hepatitis C (HCV) NS3/4 protease

InterMune announced today the presentation of preclinical data on the discovery and characterization of a number of potent and selective small molecule inhibitors of the hepatitis C (HCV) NS3/4 protease.

1 Nov 2004

Pegasys with ribavirin combo may best for reducing hepatitis C viral levels

Interim study results indicate a certain drug combination treatment may suppress the hepatitis C virus more quickly than another.

1 Nov 2004

Routine screening of blood samples would reduce the risk of disease transmission among transplant recipients

Results of a study in this week’s issue of THE LANCET suggest that routine screening of blood samples to detect viral RNA among organ and tissue donors who do not have obvious signs of clinical disease would reduce the risk of disease transmission among transplant recipients.

29 Oct 2004

New study of blood substitute for use in trauma cases

The Virginia Commonwealth University Medical Center launched a study Monday on an experimental blood substitute, PolyHeme, that will be given to critically injured and bleeding victims before they arrive at the hospital.

26 Oct 2004

Scientists are testing the effectiveness of a new type of flu vaccine

The experimental vaccine instead relies on a cell line drawn from insects known as silk moths, which are better known for their role as pests attacking crops such as corn, cotton, barley and alfalfa.

25 Oct 2004

Stable liquid technology will enable vaccines to be stored for long periods without refrigeration and reconstitution

A UK vaccine technology that is set to revolutionise the industry has received £950k funding from the Department for International Development (DFID) to bring to production a pentavalent childhood vaccine that can be stored without refrigeration.

25 Oct 2004

Hepatitis C infection increases likelihood of developing non-Hodgkin's lymphoma significantly

Patients infected with the hepatitis C virus (HCV) are six times as likely to develop non-Hodgkin's lymphoma (NHL) than individuals that are virus free, according to research presented at the Third Annual Frontiers in Cancer Prevention Research meeting.

18 Oct 2004

Malaria vaccine candidate looks extremely promising

In a proof-of-concept study published this week in The Lancet, researchers report that GlaxoSmithKline's RTS,S/AS02A malaria vaccine candidate protected a significant percentage of children against uncomplicated malaria, infection, and even severe forms of the disease for at least six months.

16 Oct 2004

Infections among injecting drug users are a growing public health concern in the UK

New figures published by the UK's Health Protection Agency show that infections among injecting drug users (IDUs) are a growing public health concern.

13 Oct 2004

Viruses from human sources occur in the La Crosse, Wisconsin municipal drinking water supply prior to its chlorination

Although the city's treated water meets or exceeds state and federal standards for drinking water, researchers and public health officials agree that more study is needed to pinpoint sources of the viruses and to determine if some viruses are surviving chlorination and making people sick with diarrhea and vomiting.

6 Oct 2004

One group of drugs that is effective in fighting HIV may also be promoting the death of sensory nerves in the skin

One group of drugs that is effective in fighting HIV may, paradoxically, also be promoting the death of sensory nerves in the skin, according to a study presented October 5, 2004, at the 129th annual meeting of the American Neurological Association in Toronto.

5 Oct 2004

Hepatitis B News and Research

Latest Hepatitis B News and Research

Hep C and HIV among injecting drug users in London are higher than expected

Caspase levels associated with liver injury

Prevalence of occult HBV in hemodialysis patients is 4 to 5 times higher than standard HBsAg testing would suggest

Britain should adopt universal hepatitis B immunisation

Researchers identify biomarkers that could lead to more accurate diagnosis of systemic lupus erythematosus

Health professionals fall short for Hepatitis C patients

Analysis of safety syringe market

Program triples hepatitis B vaccination rates in targeted regions of rural China

New approaches for the treatment of chronic hepatitis C

Discovery of a number of potent and selective small molecule inhibitors of the hepatitis C (HCV) NS3/4 protease

Pegasys with ribavirin combo may best for reducing hepatitis C viral levels

Routine screening of blood samples would reduce the risk of disease transmission among transplant recipients

New study of blood substitute for use in trauma cases

Scientists are testing the effectiveness of a new type of flu vaccine

Stable liquid technology will enable vaccines to be stored for long periods without refrigeration and reconstitution

Hepatitis C infection increases likelihood of developing non-Hodgkin's lymphoma significantly

Malaria vaccine candidate looks extremely promising

Infections among injecting drug users are a growing public health concern in the UK

Viruses from human sources occur in the La Crosse, Wisconsin municipal drinking water supply prior to its chlorination

One group of drugs that is effective in fighting HIV may also be promoting the death of sensory nerves in the skin

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Hepatitis B News and Research

Latest Hepatitis B News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in